AU7620600A - Use of pramipexole as a treatment for ***e craving - Google Patents

Use of pramipexole as a treatment for ***e craving

Info

Publication number
AU7620600A
AU7620600A AU76206/00A AU7620600A AU7620600A AU 7620600 A AU7620600 A AU 7620600A AU 76206/00 A AU76206/00 A AU 76206/00A AU 7620600 A AU7620600 A AU 7620600A AU 7620600 A AU7620600 A AU 7620600A
Authority
AU
Australia
Prior art keywords
pramipexole
treatment
***e craving
craving
***e
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76206/00A
Inventor
Jerrold Rosenbaum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU7620600A publication Critical patent/AU7620600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
AU76206/00A 1999-09-30 2000-09-28 Use of pramipexole as a treatment for ***e craving Abandoned AU7620600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15686099P 1999-09-30 1999-09-30
US60156860 1999-09-30
PCT/US2000/026634 WO2001022820A1 (en) 1999-09-30 2000-09-28 Use of pramipexole as a treatment for ***e craving

Publications (1)

Publication Number Publication Date
AU7620600A true AU7620600A (en) 2001-04-30

Family

ID=22561399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76206/00A Abandoned AU7620600A (en) 1999-09-30 2000-09-28 Use of pramipexole as a treatment for ***e craving

Country Status (3)

Country Link
AU (1) AU7620600A (en)
CA (1) CA2384840A1 (en)
WO (1) WO2001022820A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011074A1 (en) 2000-02-23 2001-10-04 Upjohn Co USE OF PRAMIPEXOL IN THE TREATMENT OF ADDICTION DISORDERS
EP2305253A1 (en) 2001-12-11 2011-04-06 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
US8679533B2 (en) 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
US20070196481A1 (en) * 2002-07-25 2007-08-23 Amidon Gregory E Sustained-release tablet composition
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
AU2003297503A1 (en) * 2002-12-31 2004-07-29 Medtronic Minimed, Inc. Hydrophilic cross-linking agents for use in enzymatic sensors
KR101052436B1 (en) 2004-08-13 2011-07-29 베링거 인겔하임 인터내셔날 게엠베하 Extended release tablet formulations containing pramipexole or pharmaceutically acceptable salts thereof, methods of preparation and uses thereof
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
PL2026803T3 (en) 2006-05-16 2012-05-31 Knopp Neurosciences Inc Compositions of r(+) and s(-) pramipexole and methods of using the same
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
RU2454409C2 (en) 2007-03-14 2012-06-27 Нопп Ньюросайенсиз, Инк. Synthesis of chirally pure substituted benzothiazole diamines
KR20110071064A (en) 2008-08-19 2011-06-28 크놉 뉴로사이언시스 인코포레이티드 Compositions and methods of using (r)-pramipexole
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
SI3019167T1 (en) 2013-07-12 2021-04-30 Knopp Biosciences Llc Treating elevated levels of eosinophils and/or basophils
US9763918B2 (en) 2013-08-13 2017-09-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders

Also Published As

Publication number Publication date
WO2001022820A1 (en) 2001-04-05
CA2384840A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU7620600A (en) Use of pramipexole as a treatment for ***e craving
AU5276600A (en) Kit for flushing medical devices and method of preparing the flushing solution
AU2935200A (en) Compounds for the treatment of obesity
IL147669A0 (en) Method for transdifferentiation of body tissues
AU5419500A (en) Bacteriophage rm 378 of a thermophilic host organism
AU782631C (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
AU4364400A (en) Azaindole derivatives for the treatment of depression
IL144590A0 (en) A process for the preparation of epothilone derivatives
AU3639201A (en) Method of randomizing patients in a clinical trial
AU2021601A (en) Composition for the treatment of dandruff
AU5831500A (en) Process for the preparation of polyols
AU6076000A (en) Cyclic amine derivatives for the treatment of neurological diseases
AU2566201A (en) Compounds and methods for the treatment of pain
AU1055201A (en) Cells capable of differentiating into heart muscle cells
AU5421200A (en) A body treatment apparatus
AU1405001A (en) Treatment of diseases
IL134144A0 (en) Process for the preparation of organic azides
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU5647200A (en) Method for modelling a human body
AUPQ048899A0 (en) A method for the diagnosis and treatment of cancer and agents useful therefor
AU6875800A (en) Heterocyclic compounds and process for the preparation thereof
AU2785999A (en) Use of succinate as a diagnostic tool
AU2382601A (en) Novel method of treatment
AUPQ199999A0 (en) A method of treatment and agents useful for same
AU4581000A (en) Method of forming a can body

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase